Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR–ABL1: A report of three cases from India

Publication date: Available online 15 December 2016
Source:Annals of Diagnostic Pathology
Author(s): Sudha Sazawal, Sunita Chikkara, Kanwaljeet Singh, Rekha Chaubey, Dinesh Chandra, Pravas Mishra, Manoranjan Mahapatra, Tulika Seth, Renu Saxena
The μ-bcr breakpoint connects exon 19 of BCR with ABL giving rise to the e19a2 transcript corresponding to the p230 fusion protein (micro-BCR breakpoint) which is rarely seen in chronic myeloid leukemia (CML) patients. Here we report three patients with p230 fusion protein presenting with different clinical presentations and diagnosed as CML-CP. These patients received Imatinib (tyrosine kinase inhibitor-TKI) and are still in remission.



http://ift.tt/2hCx6Ew